Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has acquired Sterilin, Ltd., a leading provider of single-use plastic products serving the microbiology, life sciences and clinical markets. Headquartered in South Wales, U.K., the company has approximately 270 employees and 2010 full year revenue of approximately $35 million.
"This acquisition broadens the range of innovative specialty laboratory products we can offer our customers," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "It is also consistent with our strategy to leverage our global sales and support organization to give our customers across Europe, Asia-Pacific and North America greater access to these products."
Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies